Hereditary hearing loss and deafness genes in Japan

Journal of Medical and Dental Sciences

Volumn 57, Issue 1, 2010, Pages 1-10

  Ito, Taku ^a   Noguchi, Yoshihiro ^a   Yashima, Takatoshi ^b   Ohno, Kazuchika ^a   Kitamura, Ken ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Osaki Otorhinolaryngology Clinic   (Japan)

Author keywords

12SrRNA; EYA1; GJB2; SIX1; SLC26A4

Indexed keywords

CARRIER PROTEIN; CONNEXIN 26; EYA1 PROTEIN, HUMAN; GAP JUNCTION PROTEIN; HOMEODOMAIN PROTEIN; MEMBRANE PROTEIN; NUCLEAR PROTEIN; PROTEIN TYROSINE PHOSPHATASE; RIBOSOME RNA; RNA, RIBOSOMAL, 12S; SIGNAL PEPTIDE; SIX1 PROTEIN, HUMAN; SLC26A4 PROTEIN, HUMAN; WOLFRAMIN PROTEIN;

ASIAN; CONGENITAL MALFORMATION; GENETICS; HEARING LOSS; HUMAN; JAPAN; MITOCHONDRIAL GENE; REVIEW; SYNDROME; VESTIBULE AQUEDUCT;

ASIAN CONTINENTAL ANCESTRY GROUP; CONNEXINS; GENES, MITOCHONDRIAL; HEARING LOSS; HOMEODOMAIN PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; NUCLEAR PROTEINS; PROTEIN TYROSINE PHOSPHATASES; RNA, RIBOSOMAL; SYNDROME; VESTIBULAR AQUEDUCT;

EID: 77952472695     PISSN: 13428810     EISSN: 13428810     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Smith R, Bale JJ, White K. Sensorineural hearing loss in children. Lancet 2005;365:879-90.
2. Hilgert N, Smith R, Van Camp G. Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat Res 2009;681:189-96.
3. Fortnum H, Summerfield A, Marshall D, et al. Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study. BMJ 2001;323:536-40.
4. Morton C, Nance W. Newborn hearing screening--a silent revolution. N Engl J Med 2006;354:2151-64.
5. Wrightson A. Universal newborn hearing screening. Am Fam Physician 2007;75:1349-52.
6. Fukushima K, Mimaki N, Fukuda S, et al. Pilot study of universal newborn hearing screening in Japan: districtbased screening program in Okayama. Ann Otol Rhinol Laryngol 2008;117:166-71.
7. Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, et al. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, and Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Pediatrics 2000;106:798-817.
8. Morton N. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 1991;630:16-31.
9. Van Camp G, Willems P, Smith R. Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet 1997;60:758-64.
10. Cremers CWRJ, Smith RJ. Genetic hearing impairment. Switzerland: Kager; 2002.
11. Gorlin RJ, Toriello HV, Cohen MM,. Hereditary Hearing Loss and its Syndromes. NewYork: Oxford University Press; 1995.
12. Fraser G. The causes of profound deafness in childhood. Baltimore: Johns Hopkins University Press; 1976.
13. Usami S, Wagatsuma M, Fukuoka H, et al. The responsible genes in Japanese deafness patients and clinical application using Invader assay. Acta Otolaryngol 2008;128:446-54.
14. Fuse Y, Doi K, Hasegawa T, et al. Three novel connexin26 gene mutations in autosomal recessive non-syndromic deafness. Neuroreport 1999;10:1853-7.
15. Kitamura K, Takahashi K, Noguchi Y, et al. Mutations of the Pendred syndrome gene (PDS) in patients with large vestibular aqueduct. Acta Otolaryngol 2000;120:137-41.
16. Noguchi Y, Yashima T, Ito T, et al. Audiovestibular findings in patients with mitochondrial A1555G mutation. Laryngoscope 2004;114:344-8.
17. Kitamura K, Takahashi K, Tamagawa Y, et al. Deafness genes. J Med Dent Sci 2000;47:1-11.
18. Zelante L, Gasparini P, Estivill X, et al. Connexin26 mutations associated with the most common form of nonsyndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet 1997; 6:1605-9.
19. Estivill X, Fortina P, Surrey S, et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998;351:394-8.
20. Kelley P, Harris D, Comer B, et al. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet 1998;62:792-9.
21. Bruzzone R, White T, Paul D. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 1996;238:1-27.
22. Martínez A, Acuña R, Figueroa V, et al. Gap-junction channels dysfunction in deafness and hearing loss. Antioxid Redox Signal 2009;11:309-22.
23. Stauffer K. The gap junction proteins beta 1-connexin (connexin-32) and beta 2-connexin (connexin-26) can form heteromeric hemichannels. J Biol Chem 1995;270:6768-72.
24. Kikuchi T, Kimura R, Paul D, et al. Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat Embryol (Berl) 1995;191:101-18.
25. Kelsell D, Dunlop J, Stevens H, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997;387:80-3.
26. Denoyelle F, Lina-Granade G, Plauchu H, et al. Connexin 26 gene linked to a dominant deafness. Nature 1998;393:319-20.
27. Snoeckx R, Huygen P, Feldmann D, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 2005;77:945-57.
28. Green G, Scott D, McDonald J, et al. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA 1999;281:2211-6.
29. Shahin H, Walsh T, Sobe T, et al. Genetics of congenital deafness in the Palestinian population: multiple connexin 26 alleles with shared origins in the Middle East. Hum Genet 2002;110:284-9.
30. Liu X, Xia X, Ke X, et al. The prevalence of connexin 26 (GJB2) mutations in the Chinese population. Hum Genet 2002;111:394-7.
31. Mahdieh N, Nishimura C, Ali-Madadi K, et al. The frequency of GJB2 mutations and the Delta (GJB6-D13S1830) deletion as a cause of autosomal recessive nonsyndromic deafness in the Kurdish population. Clin Genet 2004;65:506-8.
32. Posukh O, Pallares-Ruiz N, Tadinova V, et al. First molecular screening of deafness in the Altai Republic population. BMC Med Genet 2005;6:12.
33. Ohtsuka A, Yuge I, Kimura S, et al. GJB2 deafness gene shows a specific spectrum of mutations in Japan, including a frequent founder mutation. Hum Genet 2003;112:329-33.
34. Oguchi T, Ohtsuka A, Hashimoto S, et al. Clinical features of patients with GJB2 (connexin 26) mutations: severity of hearing loss is correlated with genotypes and protein expression patterns. J Hum Genet 2005;50:76-83.
35. Scrimshaw B, Faed J, Tate W, et al. Rapid identification of an A1555G mutation in human mitochondrial DNA implicated in aminoglycoside-induced ototoxicity. J Hum Genet 1999;44:388-90.
36. Kupka S, Tóth T, Wróbel M, et al. Mutation A1555G in the 12S rRNA gene and its epidemiological importance in German, Hungarian, and Polish patients. Hum Mutat 2002;19:308-9.
37. Tekin M, Duman T, Boǧoçlu G, et al. Frequency of mtDNA A1555G and A7445G mutations among children with prelingual deafness in Turkey. Eur J Pediatr 2003; 162:154-8.
38. ØStergaard E, Montserrat-Sentis B, Grønskov K, et al. The A1555G mtDNA mutation in Danish hearing-impaired patients: frequency and clinical signs. Clin Genet 2002;62:303-5.
39. Bitner-Glindzicz M, Pembrey M, Duncan A, et al. Prevalence of mitochondrial 1555A>G mutation in European children. N Engl J Med 2009;360:640-2.
40. Vandebona H, Mitchell P, Manwaring N, et al. Prevalence of mitochondrial 1555A>G mutation in adults of European descent. N Engl J Med 2009;360:642-4.
41. Malik S, Pieter N, Sudoyo H, et al. Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness patients in island Southeast Asia. J Hum Genet 2003;48:480-3.
42. Prezant T, Agapian J, Bohlman M, et al. Mitochondrial ribosomal RNA mutation associated with both antibioticinduced and non-syndromic deafness. Nat Genet 1993;4:289-94.
43. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Ann N Y Acad Sci 1999;884:99-109.
44. Guan M, Fischel-Ghodsian N, Attardi G. A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum Mol Genet 2000;9:1787-93.
45. Bates D. Aminoglycoside ototoxicity. Drugs Today (Barc) 2003;39:277-85.
46. Estivill X, Govea N, Barceló E, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am J Hum Genet 1998;62:27-35.
47. Bykhovskaya Y, Yang H, Taylor K, et al. Modifier locus for mitochondrial DNA disease: linkage and linkage disequilibrium mapping of a nuclear modifier gene for maternally inherited deafness. Genet Med;3:177-80.
48. Johnson K, Zheng Q, Bykhovskaya Y, et al. A nuclearmitochondrial DNA interaction affecting hearing impairment in mice. Nat Genet 2001;27:191-4.
49. Hyde G, Rubel E. Mitochondrial role in hair cell survival after injury. Otolaryngol Head Neck Surg 1995;113:530-40.
50. del Castillo F, Rodríguez-Ballesteros M, Martín Y, et al. Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss. J Med Genet 2003;40:632-6.
51. Kawashima Y, Noguchi Y, Ito T, et al. Vestibular evoked myogenic potentials in patients with the mitochondrial A1555G mutation. Laryngoscope 2009;119:1874-9.
52. Lynch E, Lee M, Morrow J, et al. Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science 1997; 278: 1315-8.
53. Bespalova I, Van Camp G, Bom S, et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet 2001;10:2501-8.
54. Verhoeven K, Van Laer L, Kirschhofer K, et al. Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet 1998;19:60-2.
55. De Leenheer E, Kunst H, McGuirt W, et al. Autosomal dominant inherited hearing impairment caused by a missense mutation in COL11A2 (DFNA13). Arch Otolaryngol Head Neck Surg 2001;127:13-7.
56. Iwasaki S, Harada D, Usami S, et al. Association of clinical features with mutation of TECTA in a family with autosomal dominant hearing loss. Arch Otolaryngol Head Neck Surg 2002;128:913-7.
57. Takeda K, Inoue H, Tanizawa Y, et al. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet 2001;10:477-84.
58. Cryns K, Sivakumaran T, Van den Ouweland J, et al. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum Mutat 2003;22:275-87.
59. Hofmann S, Philbrook C, Gerbitz K, et al. Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 2003;12:2003-12.
60. Cryns K, Thys S, Van Laer L, et al. The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells. Histochem Cell Biol 2003;119:247-56.
61. Cryns K, Pfister M, Pennings R, et al. Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small non-inactivating mutations. Hum Genet 2002;110:389-94.
62. Noguchi Y, Yashima T, Hatanaka A, et al. A mutation in Wolfram syndrome type 1 gene in a Japanese family with autosomal dominant low-frequency sensorineural hearing loss. Acta Otolaryngol 2005;125:1189-94.
63. Fukuoka H, Kanda Y, Ohta S, et al. Mutations in the WFS1 gene are a frequent cause of autosomal dominant nonsyndromic low-frequency hearing loss in Japanese. J Hum Genet 2007;52:510-5.
64. Fujikawa T, Noguchi Y, Ito T, et al. Additional heterozygous 2507A>C mutation of WFS1 in progressive hearing loss at lower frequencies. Laryngoscope 2010;120:166-71.
65. Valvassori G, Clemis J. The large vestibular aqueduct syndrome. Laryngoscope 1978;88:723-8.
66. Ito T, Noguchi Y, Yashima T, et al. SIX1 mutation associated with enlargement of the vestibular aqueduct in a patient with branchio-oto syndrome. Laryngoscope 2006;116:796-9.
67. Pendred V. Deaf-mutism and goitre. Lancet 2 1896:532.
68. Li X, Everett L, Lalwani A, et al. A mutation in PDS causes non-syndromicrecessive deafness. Nat Genet 1998;18:215-7.
69. Everett L, Glaser B, Beck J, et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997;17:411-22.
70. Wilcox E, Everett L, Li X, et al. The PDS gene, Pendred syndrome and non-syndromic deafness DFNB4. Adv Otorhinolaryngol 2000;56:145-51.
71. Campbell C, Cucci R, Prasad S, et al. Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat 2001;17:403-11.
72. Fugazzola L, Cerutti N, Mannavola D, et al. The role of pendrin in iodide regulation. Exp Clin Endocrinol Diabetes 2001;109:18-22.
73. Royaux I, Suzuki K, Mori A, et al. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulinin FRTL-5 cells. Endocrinology 2000;141:839-45.
74. Scott D, Wang R, Kreman T, et al. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet 1999;21:440-3.
75. Wangemann P, Nakaya K, Wu T, et al. Loss of cochlear HCO3- secretion causes deafness via endolymphatic acidification and inhibition of Ca2+ reabsorption in a Pendred syndrome mouse model. Am J Physiol Renal Physiol 2007;292:F1345-53.
76. Park H, Shaukat S, Liu X, et al. Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J Med Genet 2003;40:242-8.
77. Tsukamoto K, Suzuki H, Harada D, et al. Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese. Eur J Hum Genet 2003;11:916-22.
78. Coyle B, Reardon W, Herbrick J, et al. Molecular analysis of the PDS gene in Pendred syndrome. Hum Mol Genet 1998;7:1105-12.
79. Wang Q, Zhao Y, Rao S, et al. A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China. Clin Genet 2007;72:245-54.
80. Park H, Lee S, Jin H, et al. Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans. Clin Genet 2005;67:160-5.
81. Suzuki H, Oshima A, Tsukamoto K, et al. Clinical characteristics and genotype-phenotype correlation of hearing loss patients with SLC26A4 mutations. Acta Otolaryngol 2007;127:1292-7.
82. Smith R, Schwartz C. Branchio-oto-renal syndrome. J Commun Disord 1998;31:411-20; quiz 21.
83. Stinckens C, Standaert L, Casselman J, et al. The presence of a widened vestibular aqueduct and progressive sensorineural hearing loss in the branchiooto-renal syndrome. A family study. Int J Pediatr Otorhinolaryngol 2001;59:163-72.
84. Kemperman M, Koch S, Kumar S, et al. Evidence of progression and fluctuation of hearing impairment in branchio-oto-renal syndrome. Int J Audiol 2004;43:523-32.
85. Fraser F, Ling D, Clogg D, et al. Genetic aspects of the BOR syndrome--branchial fistulas, ear pits, hearing loss, and renal anomalies. Am J Med Genet 1978;2:241-52.
86. Ozaki H, Nakamura K, Funahashi J, et al. Six1 controls patterning of the mouse otic vesicle. Development 2004;131:551-62.
87. Zimmerman J, Bui Q, Steingrímsson E, et al. Cloning and characterization of two vertebrate homologs of the Drosophila eyes absent gene. Genome Res 1997;7:128-41.
88. Abdelhak S, Kalatzis V, Heilig R, et al. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997;15:157-64.
89. Xu P, Adams J, Peters H, et al. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 1999;23:113-7.
90. Hoskins B, Cramer C, Silvius D, et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet 2007;80:800-4.
91. Chang E, Menezes M, Meyer N, et al. Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum Mutat 2004;23:582-9.
92. Ruf R, Xu P, Silvius D, et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A 2004; 101:8090-5.
93. Yashima T, Noguchi Y, Ishikawa K, et al. Mutation of the EYA1 gene in patients with branchio-oto syndrome. Acta Otolaryngol 2003;123:279-82.